Study design

retrospective

Study time

2009.6-2017.12

Country

Turkey

Object

patients who underwent RARP

Inclusion criteria

Patients with no post_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x0002_operative PSA values or follow-up of other parameters and with previous neoadjuvant therapy (n = 398) were excluded

Robots remarks

A transperitoneal RARP procedure was performed on all patients.

Sample size

875

Topic classification

PredictionOther prognosis

Keypoint

Factors associated with aggressive disease can predict the PSA persistence.

Year